Abstract

This work examines the impact of comorbidities on the symptom burden of cancer patients prescribed oral oncolytic agents (OOA). With the increasing prescriptions of OOAs and the continued prevalence of chronic conditions, these patients are at risk for increased symptom burden with minimal strategies to manage their conditions.

Author Details

Eric A. Vachon, BSN; Barbara A. Given, PhD -- College of Nursing, Michigan State University, East Lansing, MI, USA

Sigma Membership

Unknown

Lead Author Affiliation

Michigan State University, East Lansing, Michigan, USA

Type

Poster

Format Type

Text-based Document

Study Design/Type

N/A

Research Approach

N/A

Keywords:

Cancer Symptom Management, Comorbid Conditions, Oral Oncolytic Agents

Conference Name

28th International Nursing Research Congress

Conference Host

Sigma Theta Tau International

Conference Location

Dublin, Ireland

Conference Year

2017

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Review Type

0 1

Acquisition

Proxy-submission

Additional Files

download (55 kB)

Share

COinS
 

Influence of comorbidities on symptom severity in cancer patients

Dublin, Ireland

This work examines the impact of comorbidities on the symptom burden of cancer patients prescribed oral oncolytic agents (OOA). With the increasing prescriptions of OOAs and the continued prevalence of chronic conditions, these patients are at risk for increased symptom burden with minimal strategies to manage their conditions.